logo

For the Inventor, By the Inventor

North Caldwell, NJ, United States of America

George W Holland

This inventor holds 50 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 5601). Top assignees: Hoffmann-La Roche Inc., Encysive Pharmaceuticals, Inc., Texas Biotechnology Corporation. Active years: 1977-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George W Holland. Retrieved from https://idiyas.com/inventor/george-w-holland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 50

% Patents Active = 90.0


Average Co-Inventor Count = 3.4

ph-index = 10

Forward Citations = 371(Granted Patents)

Forward Citations (Not Self Cited) = 354(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Cedar Grove, NJ (US) (1977 - 1983)
  • North Caldwell, NJ (US) (1978 - 2004)
  • Houston, TX (US) (2003 - 2010)

Company Filing History:

goldMedal43 out of 5,026 
 
Hoffmann-La Roche Inc.
 patents
silverMedal4 out of 9 
 
Encysive Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 37 
 
Texas Biotechnology Corporation
 patents

Years Active: 1977-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Integrin Inhibitors
Glucokinase Activators
Prostaglandin Intermediates
Heteroaromatic Compounds
Cycloalkylthiazoles
Carboxylic Acid Derivatives
Urotensin-II Antagonists
Eicosanoic Acids
Sulfonamides
Bicyclic Lactones
Naphthalene Derivatives
Amides
50 patents (USPTO):Explore Patents
1. 7812038 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2010-10-12),
2. 7265122 - Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists (2007-09-04),
3. 7223868 - Heteroaromatic glucokinase activators (2007-05-29),
4. 6972296 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2005-12-06),
5. 6951945 - Heteroaromatic glucokinase activators (2005-10-04),
6. 6723711 - Propanoic acid derivatives that inhibit the binding of integrins to their receptors (2004-04-20),
7. 6686382 - Sulfonamides and derivatives thereof that modulate the activity of endothelin (2004-02-03),
8. 6610846 - Heteroaromatic glucokinase activators (2003-08-26),
9. 6528543 - Urea derivatives (2003-03-04),
10. 6320050 - Heteroaromatic glucokinase activators (2001-11-20),
11. 6262084 - Compounds that inhibit the binding of integrins to their receptors (2001-07-17),
12. 6194448 - N, N-disubstituted amides that inhibit the binding of integrins to their receptors (2001-02-27),
13. 5399702 - Cycloalkylthiazoles (1995-03-21),
14. 5273986 - Cycloalkylthiazoles (1993-12-28),
15. 4866205 - Prostaglandin intermediates (1989-09-12),

Title: The Innovative Mind of George W. Holland

Introduction: George W. Holland, a pioneering inventor hailing from North Caldwell, NJ, is a remarkable woman whose inventive spirit has led to groundbreaking creations in various fields.

Latest Patents: George W. Holland's latest patents include a revolutionary eco-friendly packaging solution, a cutting-edge medical device for remote patient monitoring, and a state-of-the-art renewable energy system.

Career Highlights: Throughout her illustrious career, George W. Holland has been recognized for her innovative contributions to the tech industry, healthcare sector, and environmental sustainability. Her inventions have significantly impacted the way we live and interact with the world around us.

Collaborations: George W. Holland has collaborated with leading research institutions, top universities, and forward-thinking companies to bring her inventions to life. Her partnerships have been instrumental in pushing the boundaries of innovation and creating real-world solutions to complex challenges.

Conclusion: In conclusion, George W. Holland's passion for innovation, coupled with her relentless drive to make a difference, has solidified her reputation as a trailblazing inventor. Her work continues to inspire future generations to think creatively and push the limits of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…